Efficacy and safety of pharmacotherapy for Alzheimer’s disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy and safety of pharmacotherapy for Alzheimer’s disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials ; volume:13 ; number:1 ; day:16 ; month:7 ; year:2021 ; pages:1-20 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (16.7.2021), 1-20, 12.2021
- Urheber
-
Seibert, M.
Mühlbauer, V.
Holbrook, J.
Voigt-Radloff, S.
Brefka, S.
Dallmeier, D.
Denkinger, M.
Schönfeldt-Lecuona, C.
Klöppel, S.
Arnim, C. A. F. von
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-021-00867-8
- URN
-
urn:nbn:de:101:1-2021102022011169227067
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Seibert, M.
- Mühlbauer, V.
- Holbrook, J.
- Voigt-Radloff, S.
- Brefka, S.
- Dallmeier, D.
- Denkinger, M.
- Schönfeldt-Lecuona, C.
- Klöppel, S.
- Arnim, C. A. F. von
- SpringerLink (Online service)
Ähnliche Objekte (12)
Efficacy and safety of pharmacotherapy for Alzheimer’s disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease
Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease
Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
Extract of Cynomorium songaricum ameliorates mitochondrial ultrastructure impairments and dysfunction in two different in vitro models of Alzheimer’s disease
Molecular mechanisms and genetics of Alzheimer’s disease
Genomics and Functional Genomics of Alzheimer’s Disease
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
Tetrahedral framework nucleic acids inhibit Aβ-mediated ferroptosis and ameliorate cognitive and synaptic impairments in Alzheimer’s disease
Measuring knowledge of Alzheimer’s: development and psychometric testing of the UJA Alzheimer’s Care Scale
Efficacy and safety of pharmacotherapy for Alzheimer’s disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease
Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease
Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
Extract of Cynomorium songaricum ameliorates mitochondrial ultrastructure impairments and dysfunction in two different in vitro models of Alzheimer’s disease
Molecular mechanisms and genetics of Alzheimer’s disease
Genomics and Functional Genomics of Alzheimer’s Disease
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
Tetrahedral framework nucleic acids inhibit Aβ-mediated ferroptosis and ameliorate cognitive and synaptic impairments in Alzheimer’s disease
Measuring knowledge of Alzheimer’s: development and psychometric testing of the UJA Alzheimer’s Care Scale
Efficacy and safety of pharmacotherapy for Alzheimer’s disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease
Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease
Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
Extract of Cynomorium songaricum ameliorates mitochondrial ultrastructure impairments and dysfunction in two different in vitro models of Alzheimer’s disease
Molecular mechanisms and genetics of Alzheimer’s disease
Genomics and Functional Genomics of Alzheimer’s Disease
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
Tetrahedral framework nucleic acids inhibit Aβ-mediated ferroptosis and ameliorate cognitive and synaptic impairments in Alzheimer’s disease